• AIDS
  • 200) and progression times to AIDS and death. (ox.ac.uk)
  • During HIV/AIDS micronutrients play a key role in the host defense systems-Micronutrients such as zinc and copper have been implicated to play important roles in immuno-physiologic functions. (asrjetsjournal.org)
  • As potent antiretroviral therapy for HIV has decreased AIDS-associated morbidity and mortality, chronic HCV has become a significant cause of morbidity and mortality in this population. (natap.org)
  • In the vast majority of those infected with HIV virus who are untreated, there is deterioration in immune health over a period of months or years inevitably leading to full-blown AIDS and demise. (clinicaltrials.gov)
  • The investigators' study hypothesis is that effectiveness of a very low dose of an FDA-approved medication, naltrexone hydrochloride, (Low-Dose Naltrexone, or LDN) will compare favorably to ARV's to prevent progression of HIV+ toward immune deterioration and full-blown AIDS. (clinicaltrials.gov)
  • survival
  • This study is designed as a Phase III, multicenter trial, comparing progression-free survival (PFS) after autologous hematopoietic stem cell transplantation using a standard Rituxan plus BEAM transplant regimen versus a regimen adding Bexxar to BEAM. (clinicaltrials.gov)
  • Therefore, the primary endpoint of this study will be to compare progression-free survival after autologous hematopoietic stem cell transplantation for chemotherapy-sensitive diffuse large B-cell lymphoma using Rituxan/BEAM versus Bexxar/BEAM for pre-transplant conditioning. (clinicaltrials.gov)
  • years
  • Descriptive cross-sectional study was conducted in the voluntary counselling and testing centre (VCT) at Comprehensive Care Clinics in Taita-Taveta County health care services, Coast, Kenya, blood samples obtained from 192 HIV sero-positive individuals, 18 years of age and gender matched healthy controls were analyzed for zinc and copper using atomic absorption spectrophotometer machine. (asrjetsjournal.org)
  • study
  • This is the first population-based study with adequate sample size that tests if SCD could protect from HIV. (pubmedcentralcanada.ca)
  • This locus in part of the HLA A1-B8-DR3-DQ2 haplotype (markers are A1, CW7, B8, BfS, C4AQ0, C4B1, DR3, DQ2) therefore one study concluded that C4AQ0 could explain the increased infectivity to HIV. (wikipedia.org)
  • death
  • Factors influencing T cell activation and programmed death 1 expression in HIV-infected children. (ox.ac.uk)
  • cell
  • Both CD8 activation and PD-1 expression were partially driven by the magnitude of the HIV-specific CD8(+) T cell response. (ox.ac.uk)
  • however
  • Therapy for HIV in the context of HCV coinfection, however, can be problematic. (natap.org)